Skip to main content
. 2024 Dec 19;23:15330338241308307. doi: 10.1177/15330338241308307

Table 1.

Comparative Analysis of Clinical-Radiological Features Between Training and Validation Datasets.

Variables Total (n = 1383) Training dataset (n = 922) Validation dataset (n = 461) P-value
Label, n (%) .131
 Non-IMA 1273 (92) 841 (91.2) 432 (93.7)
 IMA 110 (8) 81 (8.8) 29 (6.3)
Sex, n (%) .310
 Female 894 (64.6) 587 (63.7) 307 (66.6)
 Male 489 (35.4) 335 (36.3) 154 (33.4)
Age, Median (Q1, Q3) 57 (51, 66) 57 (51, 66) 58 (51, 66) .349
Laterality, n (%) .385
 Left 570 (41.2) 388 (42.1) 182 (39.5)
 Right 813 (58.8) 534 (57.9) 279 (60.5)
Primary site, n (%) .236
 Lower lobe 472 (34.1) 303 (32.9) 169 (36.7)
 Middle lobe 105 (7.6) 67 (7.3) 38 (8.2)
 Upper lobe 806 (58.3) 552 (59.9) 254 (55.1)
Clinical T stage, n (%) .945
 cT1a 94 (6.8) 64 (6.9) 30 (6.5)
 cT1b 723 (52.3) 480 (52.1) 243 (52.7)
 cT1c 566 (40.9) 378 (41) 188 (40.8)
CT density, n (%) .487
 GGN 580 (41.9) 390 (42.3) 190 (41.2)
 SN 449 (32.5) 305 (33.1) 144 (31.2)
 SSN 354 (25.6) 227 (24.6) 127 (27.5)
Margin, n (%) .801
 Ill-defined 305 (22.1) 201 (21.8) 104 (22.6)
 Well-defined 1078 (77.9) 721 (78.2) 357 (77.4)
Shape, n (%) .245
 Irregular 637 (46.1) 414 (44.9) 223 (48.4)
 Round/oval 746 (53.9) 508 (55.1) 238 (51.6)
Lobulation, n (%) .629
 Absence 566 (40.9) 382 (41.4) 184 (39.9)
 Presence 817 (59.1) 540 (58.6) 277 (60.1)
Spiculation, n (%) .371
 Absence 685 (49.5) 465 (50.4) 220 (47.7)
 Presence 698 (50.5) 457 (49.6) 241 (52.3)
Vascular change, n (%) .486
 Absence 322 (23.3) 209 (22.7) 113 (24.5)
 Presence 1061 (76.7) 713 (77.3) 348 (75.5)
Bubble lucency, n (%) .050
 Absence 1114 (80.5) 757 (82.1) 357 (77.4)
 Presence 269 (19.5) 165 (17.9) 104 (22.6)
Pleural indentation, n (%) .067
 Absence 574 (41.5) 399 (43.3) 175 (38)
 Presence 809 (58.5) 523 (56.7) 286 (62)

Abbreviation: GGN, ground-glass nodule; SN, solid nodule; SSN, subsolid nodule; IMA, invasive mucinous adenocarcinoma.